HeXun Biosciences Co., Ltd.
6986StockTWO
60.60 ▲ +0.66%
Jun 12, 2026
6
HeXun Biosciences Co., Ltd.
60.60 ▲ +0.66%
Jun 12, 2026
6986StockTWO

About the company

HeXun Biosciences Co., Ltd. engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan. It provides contract manufacturing; commissioned inspection; aseptic filling; and consulting services. The company was founded in 2019 and is based in Taoyuan City, Taiwan.

Arberion
Loading market data